Purpose: Overactive bladder (OAB) is a clinical syndrome that is currently treated ini-tially with anticholinergics, although some other therapeutic alternatives exist, such as neuromodulation, botulinum toxin, and posterior tibial nerve stimulation (PTNS). The purpose of this study was to assess the efficacy of PTNS in patients with OAB re-fractory to anticholinergics. Materials and Methods: We present a cohort study of 14 women with OAB to whom we applied PTNS. We assessed (before and after the treatment) the diurnal micturi-tional frequency, the nocturnal micturitional frequency, urgency episodes, and urge incontinence episodes. Results were analyzed by using the Wilcoxon test for non-parametric samples. Results: We observed statisticall...
Background: Overactive bladder (OAB) symptoms of frequency, urgency and urge incontinence are freque...
BACKGROUND: Around 16% of adults have symptoms of overactive bladder (urgency with frequency and/or ...
Keywords: Neurogenic detrusor overactivity Context: The use of botulinum toxin A (BoNTA) in the trea...
Overactive bladder (OAB) is a common condition that is experienced by around 455 million people (11%...
Abstract PURPOSE OF REVIEW: We have reviewed the evidence published on botulinum toxin A (BoNT/A...
Purpose: We assessed the impact of transobturator tape (TOT) treatment on overactive bladder (OAB) s...
International audienceCONTEXT:A considerable number of patients affected by the overactive bladder s...
Introduction and hypothesis: We hypothesized that patients with refractory overactive bladder (rOAB...
Contains fulltext : 177718.pdf (publisher's version ) (Open Access)Overactive blad...
PURPOSE: To assess the effect of transcutaneous electrical nerve stimulation (TENS) for treating ref...
Context: Anticholinergic drugs are commonly used in patients with overactive bladder (OAB) who do no...
PURPOSE: Recently, intermittent percutaneous posterior tibial nerve stimulation was introduced as a ...
Context: Anticholinergic drugs are commonly used in patients with overactive bladder (OAB) who do n...
Purpose: Treatment options for patients with overactive bladder refractory to anticholinergics are l...
Contains fulltext : 51953.pdf (publisher's version ) (Open Access)Nearly one out o...
Background: Overactive bladder (OAB) symptoms of frequency, urgency and urge incontinence are freque...
BACKGROUND: Around 16% of adults have symptoms of overactive bladder (urgency with frequency and/or ...
Keywords: Neurogenic detrusor overactivity Context: The use of botulinum toxin A (BoNTA) in the trea...
Overactive bladder (OAB) is a common condition that is experienced by around 455 million people (11%...
Abstract PURPOSE OF REVIEW: We have reviewed the evidence published on botulinum toxin A (BoNT/A...
Purpose: We assessed the impact of transobturator tape (TOT) treatment on overactive bladder (OAB) s...
International audienceCONTEXT:A considerable number of patients affected by the overactive bladder s...
Introduction and hypothesis: We hypothesized that patients with refractory overactive bladder (rOAB...
Contains fulltext : 177718.pdf (publisher's version ) (Open Access)Overactive blad...
PURPOSE: To assess the effect of transcutaneous electrical nerve stimulation (TENS) for treating ref...
Context: Anticholinergic drugs are commonly used in patients with overactive bladder (OAB) who do no...
PURPOSE: Recently, intermittent percutaneous posterior tibial nerve stimulation was introduced as a ...
Context: Anticholinergic drugs are commonly used in patients with overactive bladder (OAB) who do n...
Purpose: Treatment options for patients with overactive bladder refractory to anticholinergics are l...
Contains fulltext : 51953.pdf (publisher's version ) (Open Access)Nearly one out o...
Background: Overactive bladder (OAB) symptoms of frequency, urgency and urge incontinence are freque...
BACKGROUND: Around 16% of adults have symptoms of overactive bladder (urgency with frequency and/or ...
Keywords: Neurogenic detrusor overactivity Context: The use of botulinum toxin A (BoNTA) in the trea...